S. 1637In Committee
MVP Act
Authorize Medicaid drug rebate rules for value-based purchasing arrangements and adjust related Medicare payment calculations and state Medicaid guidance for prescription drugs
Plain-English overview
What this bill does
Authorize Medicaid drug rebate rules for value-based purchasing arrangements and adjust related Medicare payment calculations and state Medicaid guidance for prescription drugs
Key points
- Require GAO impact study
- Authorize multiple best prices
- Direct CMS inpatient guidance
- Exclude VBP sales prices
Current status
Where it stands
Status
In Committee
Latest action
2025-05-07 — Read twice and referred to the Committee on Finance.
Related context
Topics and policy areas
undefinedHealth